Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion 0 30.11.2023 20:56 CNBC Shares of other biotech companies developing ADCs, which are among the hottest areas in the pharmaceutical industry, jumped on the news of the buyout. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
